Matrix metalloproteinase-7 and matrix metalloproteinase-25 in oral tongue squamous cell carcinoma

Head and Neck

Volumn 36, Issue 12, 2014, Pages 1783-1788

  Makinen, Laura K ^a   Hayry, Valtteri ^a   Hagstrom, Jaana ^a,b,c   Sorsa, Timo ^a   Passador Santos, Fabricio ^b,d   Keski Santti, Harri ^a   Haukka, Jari ^c   Makitie, Antti A ^a   Haglund, Caj ^a,b   Atula, Timo ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d SÃO LEOPOLDO MANDIC INSTITUTE AND RESEARCH CENTER   (Brazil)

Author keywords

Biomarker; Immunohistochemistry; Matrix metalloproteinase; Oral cancer; Prognosis

Indexed keywords

MATRILYSIN; MATRIX METALLOPROTEINASE 25; METALLOPROTEINASE; UNCLASSIFIED DRUG; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; MATRIX METALLOPROTEINASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EVALUATION STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTIVE VALUE; PROTEIN EXPRESSION; TISSUE MICROARRAY; TONGUE CARCINOMA; TUMOR INVASION; COHORT ANALYSIS; ENZYMOLOGY; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TONGUE TUMOR; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; GPI-LINKED PROTEINS; HUMANS; MALE; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TISSUE ARRAY ANALYSIS; TONGUE NEOPLASMS; YOUNG ADULT;

EID: 84912003033     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23539     Document Type: Article

References (39)

1. Ferlito A, Rinaldo A, Devaney KO, et al. Prognostic significance of microscopic and macroscopic extracapsular spread from metastatic tumor in the cervical lymph nodes. Oral Oncol 2002;38: 747-751.
2. Ferlito A, Shaha AR, Rinaldo A. The incidence of lymph node micrometastases in patients pathologically staged N0 in cancer of oral cavity and oropharynx. Oral Oncol 2002;38: 3-5.
3. Howell GM, Grandis JR. Molecular mediators of metastasis in head and neck squamous cell carcinoma. Head Neck 2005;27: 710-717.
4. Keski-Santti H, Atula T, Tikka J, Hollmen J, Makitie AA, Leivo I. Predictive value of histopathologic parameters in early squamous cell carcinoma of oral tongue. Oral Oncol 2007;43: 1007-1013.
5. Al-Rajhi N, Khafaga Y, El-Husseiny J, et al. Early stage carcinoma of oral tongue: Prognostic factors for local control and survival. Oral Oncol 2000; 36: 508-514.
6. Arduino PG, Carrozzo M, Chiecchio A, et al. Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: A retrospective study of 334 cases. J Oral Maxillofac Surg 2008;66: 1570-1579.
7. Woolgar JA. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol 2006;42: 229-239.
8. Hua H, Li M, Luo T, Yin Y, Jiang Y. Matrix metalloproteinases in tumorigenesis: An evolving paradigm. Cell Mol Life Sci 2011;68: 3853-3868.
9. Sorsa T, Tjaderhane L, Konttinen YT, et al. Matrix metalloproteinases: Contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 2006;38: 306-321.
10. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006;25: 9-34.
11. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T. Regulation of matrix metalloproteinases: An overview. Mol Cell Biochem 2003;253: 269-285.
12. Yamamoto H, Itoh F, Iku S, et al. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: Clinicopathologic and prognostic significance of matrilysin expression. J Clin Oncol 2001;19: 1118-1127.
13. Wang WS, Chen PM, Wang HS, Liang WY, Su Y. Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma. Carcinogenesis 2006;27: 1113-1120.
14. Fang YJ, Pan ZZ, Li LR, Lu ZH, Zhang LY, Wan DS. MMP7 expression regulated by endocrine therapy in ERbeta-positive colon cancer cells. J Exp Clin Cancer Res 2009;28: 132.
15. Yang B, Su K, Gao J, Rao Z. Expression and prognostic value of matrix metalloproteinase-7 in colorectal cancer. Asian Pac J Cancer Prev 2012; 13: 1049-1052.
16. Fanelli MF, Chinen LT, Begnami MD, et al. The influence of transforming growth factor-a, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer. Histopathology 2012;61: 153-161.
17. Hirashita T, Iwashita Y, Ohta M, et al. Expression of matrix metalloproteinase-7 is an unfavorable prognostic factor in intrahepatic cholangiocarcinoma. J Gastrointest Surg 2012;16: 842-848.
18. Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y. Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood) 2006;231: 20-27.
19. de Vicente JC, Lequerica-Fernandez P, Santamaria J, Fresno MF. Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis. J Oral Pathol Med 2007; 36: 415-424.
20. Chuang HC, Su CY, Huang HY, et al. Active matrix metalloproteinase-7 is associated with invasion in buccal squamous cell carcinoma. Mod Pathol 2008;21: 1444-1450.
21. von Bredow DC, Nagle RB, Bowden GT, Cress AE. Cleavage of beta 4 integrin by matrilysin. Exp Cell Res 1997;236: 341-345.
22. Weber A, Hengge UR, Stricker I, et al. Protein microarrays for the detection of biomarkers in head and neck squamous cell carcinomas. Hum Pathol 2007;38: 228-238.
23. Barros SS, Henriques AC, Pereira KM, de Medeiros AM, Galvao HC, Freitas Rde A. Immunohistochemical expression of matrix metalloproteinases in squamous cell carcinoma of the tongue and lower lip. Arch Oral Biol 2011;56: 752-760.
24. de Amorim RF, da Silveira EJ, Queiroz LM, Galv~ao HC, de Souza LB, de Almeida Freitas R. Matrilysins may not predict the metastatic potential in squamous cell carcinoma of the tongue. Acta Odontol Scand 2010;68: 228-231.
25. Lequerica-Fernandez P, Pe~na I, Villalain L, Rosado P, de Vicente JC. Carcinoma of the parotid gland: Developing prognostic indices. Int J Oral Maxillofac Surg 2011;40: 821-828.
26. Luukkaa H, Klemi P, Hirsimaki P, et al. Matrix metalloproteinase (MMP)- 7 in salivary gland cancer. Acta Oncol 2010;49: 85-90.
27. English WR, Holtz B, Vogt G, Knauper V, Murphy G. Characterization of the role of the "MT-loop": An eight-amino acid insertion specific to progelatinase A (MMP2) activating membrane-type matrix metalloproteinases. J Biol Chem 2001;276: 42018-42026.
28. Kuula H, Salo T, Pirila E, et al. Human beta-defensin-1 and -2 and matrix metalloproteinase-25 and -26 expression in chronic and aggressive periodontitis and in peri-implantitis. Arch Oral Biol 2008;53: 175-186.
29. Sohail A, Sun Q, Zhao H, Bernardo MM, Cho JA, Fridman R. MT4- (MMP17) and MT6-MMP (MMP25), a unique set of membrane-anchored matrix metalloproteinases: Properties and expression in cancer. Cancer Metastasis Rev 2008;27: 289-302.
30. Sun Q, Weber CR, Sohail A, et al. MMP25 (MT6-MMP) is highly expressed in human colon cancer, promotes tumor growth, and exhibits unique biochemical properties. J Biol Chem 2007;282: 21998-22010.
31. Keski-Santti H, Atula T, Tornwall J, Koivunen P, Makitie A. Elective neck treatment versus observation in patients with T1/T2 N0 squamous cell carcinoma of oral tongue. Oral Oncol 2006;42: 96-101.
32. Hayry V, Makinen LK, Atula T, et al. Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue. Br J Cancer 2010;102: 892-897.
33. Buduneli E, Vardar-Sengul S, Buduneli N, Atilla G, Wahlgren J, Sorsa T. Matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and laminin-5 gamma2 chain immunolocalization in gingival tissue of endotoxin-induced periodontitis in rats: Effects of low-dose doxycycline and alendronate. J Periodontol 2007;78: 127-134.
34. Szarvas T, Becker M, vom Dorp F, et al. Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancer. Cancer Sci 2010;101: 1300-1308.
35. Bello IO, Soini Y, Salo T. Prognostic evaluation of oral tongue cancer: Means, markers and perspectives (I). Oral Oncol 2010;46: 630-635.
36. Bello IO, Soini Y, Salo T. Prognostic evaluation of oral tongue cancer: Means, markers and perspectives (II). Oral Oncol 2010;46: 636-643.
37. Koskensalo S, Mrena J, Wiksten JP, et al. MMP-7 overexpression is an independent prognostic marker in gastric cancer. Tumour Biol 2010;31: 149-155.
38. Koskensalo S, Louhimo J, Nordling S, Hagstrom J, Haglund C. MMP-7 as a prognostic marker in colorectal cancer. Tumour Biol 2011;32: 259-264.
39. Weber A, Hengge UR, Stricker I, et al. Protein microarrays for the detection of biomarkers in head and neck squamous cell carcinomas. Hum Pathol 2007;38: 228-238.